Chesapeake Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.2K Hold
340
0.03% 170
2026
Q1
$24.4K Hold
340
0.02% 185
2025
Q4
$27K Sell
340
-200
-37% -$15.8K 0.02% 190
2025
Q3
$40.7K Hold
540
0.04% 149
2025
Q2
$37.2K Sell
540
-20
-4% -$1.31K 0.03% 151
2025
Q1
$37.9K Sell
560
-180
-24% -$10.8K 0.04% 134
2024
Q4
$33.2K Buy
740
+390
+111% +$21.9K 0.03% 146
2024
Q3
$22K Sell
350
-97
-22% -$5.66K 0.02% 166
2024
Q2
$26.4K Buy
447
+1
+0.2% +$63 0.03% 150
2024
Q1
$35.6K Sell
446
-10
-2% -$764 0.04% 132
2023
Q4
$36K Hold
456
0.03% 152
2023
Q3
$31.8K Buy
456
+116
+34% +$8.22K 0.03% 167
2023
Q2
$23.5K Hold
340
0.02% 181
2023
Q1
$25.3K Buy
+340
New +$28.5K 0.02% 171

Other funds holding CVS

Chesapeake Asset Management's CVS Position: Q2 2026 in Review

Chesapeake Asset Management held its CVS Health (CVS) position steady in Q2 2026 at 340 shares worth $35.2K. The position accounts for 0.03% of the portfolio, ranked #170.

Chesapeake Asset Management first reported a position in CVS in Q1 2023 and has held it in 14 quarters since. The position peaked at $40.7K in Q3 2025. 2,068 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Chesapeake Asset Management held 340 shares of CVS Health worth $35.2K as of Q2 2026.
  • Chesapeake Asset Management left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.03% of Chesapeake Asset Management's portfolio in Q2 2026, its #170 holding.
  • Chesapeake Asset Management first reported a position in CVS Health in Q1 2023 and has held it in 14 quarters since.
  • Chesapeake Asset Management's CVS Health position peaked at $40.7K in Q3 2025.
  • 2,068 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.